The Shotlee Journal
Browse Shotlee articles about Ozempic.
Showing 9 / 1088 Ozempic articles
The UK's MHRA has issued a critical warning about counterfeit Mounjaro pens following reports from Eli Lilly. These fake pens contain tirzepatide but may not be sterile, posing potential health risks. Patients are urged to verify batch numbers and report suspicions to the Yellow Card scheme.
In eastern Denmark, Ellegaard Gottingen Minipigs A/S breeds specialized $3,000 minipigs vital to Europe's drug pipeline, including Novo Nordisk's Ozempic and Wegovy. These biosecure facilities address supply chain vulnerabilities exposed by the pandemic's monkey shortages. As the EU pushes for biotech independence, these smaller, human-like pigs offer a strategic alternative.
Just as smartphones propelled Ireland's economy post-financial crisis, GLP-1 weight-loss drugs like Eli Lilly's Mounjaro and Zepbound are set to do the same. With factories in Kinsale and Limerick producing key ingredients, Ireland eyes massive tax windfalls and export spikes. Gallup data shows US obesity falling to 37%, crediting these therapies.
As the Ozempic generation ramps up protein intake to support weight loss, Minneapolis-based Puris Proteins has surged to $200 million in revenue as America's top pea protein maker. From basement soybean breeding to supplying giants like Cargill, this family business is powering nutritious habits for GLP-1 users. Here's the story behind their explosive growth.
Eli Lilly's investigational GLP-1 pill, orforglipron, demonstrated greater weight loss and blood sugar control than oral semaglutide in a major phase 3 trial for type 2 diabetes. Patients lost 6-8% body weight compared to 4-5%, though with higher GI side effects. This could signal a shift toward more effective oral therapies.
With federal Obamacare subsidies expired, premiums have surged, but ten states are stepping in with their own aid to keep coverage affordable. New Mexico fully replaces the gap for all incomes, while others target low earners amid cost pressures from GLP-1 drugs like Ozempic and Wegovy. Enrollment trends vary, with some states seeing gains despite national drops.
GLP-1 medications are reshaping bakery demands, driving growth in high-fiber, high-protein products. Ardent Mills is leading with benefit-stacking strategies using UltraGrain flour and chickpea ingredients to support satiety and digestive health for users. This guide details the research, innovations, and future outlook.
As GLP-1 medications surge in popularity, the Institute of Food Technologists (IFT) is guiding brands on functional foods to fill nutrition gaps. From Danone’s Oikos Fusion yogurt to fiber-woven snacks by Lasso, discover how proteins, prebiotics, and micronutrients support satiety and muscle health for users.
Zydus Lifesciences is set to launch affordable semaglutide injections in India right on patent expiry, targeting the growing Type 2 diabetes and obesity crisis. With innovative reusable pens under brands like SEMAGLYN, MASHEMA, and ALTERME, the company aims to cut costs and improve patient adherence. This move could transform access to GLP-1 therapy for millions.
